Thoroughly vet and create an ACE® forecast model and deliver in 25 days. The acquisition candidate had an attractive target profile but competed in a highly genericized market. Crucial questions surrounding patient and payer acceptance had to be answered within the highly compressed timeframe.
Design and build a comprehensive ACE® forecast model for an oncology pipeline candidate with the flexibility to anticipate product and market changes. The model accounted for and accommodated the full array of possible scenarios while covering 15 global regions.
Design and build a new ACE® forecast model to deliver unprecedented accuracy. Integrating seamlessly with the existing quarterly ‘Latest Estimate’ (LE) process, it accounted for complex market events associated with specialty distribution, drew from multiple, disparate data sources, and improved on the previous model’s performance by 50%.
